Distinguished in Spontaneous Coronary Artery Dissection (SCAD)

Loghman Henareh

Stockholm, AB, SE 
Distinguished in Spontaneous Coronary Artery Dissection (SCAD)
Stockholm, AB, SE 
OverviewLocationsClinical Research

Overview

Loghman Henareh practices in Stockholm, Sweden. Henareh is rated as a Distinguished expert by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). Their top areas of expertise are Spontaneous Coronary Artery Dissection (SCAD), Heart Attack, Congenital Coronary Artery Malformation, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 57 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Spontaneous Coronary Artery Dissection (SCAD).

Locations

Stockholm, AB, Sweden
Other Locations
Karolinska Institutet
Huddinge, AB, Sweden
Danderyd, AB, Sweden
Solna, AB, Sweden
Sweden
Capio St. Görans Hospital, Uppsala, C, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Enrollment Status: Completed
Publish Date: December 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
Methylnaltrexone as a Method to imprOVE Platelet Inhibition of Ticagrelor in Morphine-treated Patients With ST-segMENT Elevation Myocardial Infarction: a Prospective, Single Blinded Randomized, Placebo-controlled Trial
Methylnaltrexone as a Method to imprOVE Platelet Inhibition of Ticagrelor in Morphine-treated Patients With ST-segMENT Elevation Myocardial Infarction: a Prospective, Single Blinded Randomized, Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: April 09, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

57 Total Publications

Reply to the commentary by Dong et al.: Appraising the CCTA-SCAD study: Current challenges and future perspectives in diagnosing acute spontaneous coronary artery dissection.
Reply to the commentary by Dong et al.: Appraising the CCTA-SCAD study: Current challenges and future perspectives in diagnosing acute spontaneous coronary artery dissection.
Journal: Journal of cardiovascular computed tomography
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Henareh's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile